Status:
COMPLETED
A Long Term Extension of Study NC19453 Evaluating Safety and Efficacy of RO4607381
Lead Sponsor:
Hoffmann-La Roche
Conditions:
Coronary Heart Disease
Eligibility:
All Genders
18-75 years
Phase:
PHASE2
Brief Summary
This 2 arm study will assess the long term safety and efficacy of RO4607381 in patients with coronary heart disease or a coronary heart disease (CHD) risk equivalent who have completed study NC19453. ...
Eligibility Criteria
Inclusion
- patients who have completed treatment on study NC19453.
Exclusion
- any significant lymph node abnormalities at the end of study NC19453.
Key Trial Info
Start Date :
January 1 2007
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
January 1 2008
Estimated Enrollment :
77 Patients enrolled
Trial Details
Trial ID
NCT00400439
Start Date
January 1 2007
End Date
January 1 2008
Last Update
January 3 2020
Active Locations (9)
Enter a location and click search to find clinical trials sorted by distance.
1
Indianapolis, Indiana, United States, 46260
2
Iowa City, Iowa, United States, 52242
3
Louisville, Kentucky, United States, 40213
4
Bethesda, Maryland, United States, 20817